What Do You Need To Know To Navigate The 'Now What?' After Early-Phase Success?

Source: Lonza

By Jeffrey O’Connor, Senior Director of Commercial Management, Lonza


Market fragmentation, rapid innovation, and the ongoing call for increased efficiency in the biopharmaceutical industry are creating unique challenges when it comes to accurately forecasting and planning for demand from clinical to commercial scale. Manufacturers must be able to anticipate and respond quickly to fluctuations, all while managing production at an optimal level. Inaccurately forecasting demand could not only be devastating to the future success of a product in its targeted patient population but also put a company at risk of losing out on vital opportunities for growth.

The solution is to incorporate a flexible operations strategy that can accommodate changing volume needs throughout the drug development journey. This calls on access to capacity, advanced solutions and technology, and expertise that can help guide the way. Therefore, while moving from early- to late-phase clinical trials is a critical milestone to celebrate on the way to commercialization, many face the same daunting question once the confetti settles ― now what?

Download the full article to find out more about how to achieve your short-term goals while establishing long-term confidence and security in today’s evolving market.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online